Background: Transient ischemic attack incurs a risk of recurrent stroke that can be dramatically reduced by urgent guideline-recommended management at the point of first medical contact.
Introduction
Transient ischemic attack (TIA) is an urgent and important problem because the risk of recurrent stroke is up to 15% within 90 days, 1 with the greatest proportion of this risk occurring in the first 48 h. 2 In Australia, stroke imposes a significant burden, causing 6% of all deaths in 2009, 3 and in 2012, more than 420,000 people were living with disability from stroke. 4 Proven management strategies for TIA can reduce relative risk of subsequent stroke by 80%, but they rely upon rapid assessment of TIA and prompt commencement of secondary prevention. 5 Evidencebased practice guidelines internationally have incorporated these management strategies. 6, 7 For Australian practice, they are detailed in the National Stroke Foundation guidelines (hereafter, guidelines). 8 The majority of patients with TIA first present to general practice, 9 but there is limited evidence describing general practitioner (GP) management of TIA. In Australia, this evidence suggests that compliance with guidelines may not be ideal. 10, 11 This poses the question of how early career GPs and GP trainees (known in Australia as GP registrars) are prepared for managing this condition. GP registrars essentially practice as independent practitioners (including for test-ordering, prescribing, specialist referral, and billing), although they have recourse to advice and support from experienced GP supervisors within a regionalized national GP training program. 12 Previous research shows that when compared to established GPs, GP registrars see substantially less chronic disease, 13 and older patients prefer to see their usual GP.
14 Increasing age is a major risk factor for TIA 7 and, unfortunately, patients often do not perceive TIA symptoms to be urgent. 15 It is unknown how these potential influences interact in determining the prevalence of TIA presentations in GP registrars' clinical experience.
GP training relies upon clinical exposure to disease conditions to reinforce good management practices. Consequently, it is important to know how often GP registrars see TIA and how they manage it.
Aims
To describe the prevalence of clinically diagnosed new TIA presentations, the associations of practice, registrar, and patient factors with new TIA presentations, and the management actions undertaken by GP registrars.
Methods Participants
This was a cross-sectional analysis of data from the Registrar Clinical Encounters in Training (ReCEnT) cohort study. Data were from 14 rounds of data collection, 2010-2016. The study methodology has been described in detail elsewhere. 16 Briefly, ReCEnT is an ongoing cohort study of GP registrars' in-practice clinical experiences undertaken (2010-2015) in 5 of Australia's then 17 regional training organizations (RTOs) and (2016) in three of Australia's current nine RTOs. These encompass urban, rural, remote, and very remote practices
Procedures
Participating GP registrar characteristics and the characteristics of their training practice are documented. Registrars record the details of 60 consecutive patient consultations, representing approximately one week of consultations, once in each of three six-month training terms. In one RTO, registrars in a fourth elective term also participated. Data collection is conducted around the midpoint of the term.
Outcome factors
The primary outcome factor was whether a new TIA problem was encountered for patients aged 18 or over. TIA was defined as an initial clinical diagnosis made by the GP registrar at first consultation following assessment of a patient presenting with a transient neurological disturbance. Problems addressed in the consultation were coded according to the International Classification of Primary Care, second edition (ICPC-2). 17 New TIA problems were defined by ICPC-2 code K89 001 (TIA), K89 014 (amaurosis fugax), K89 015 (reversible ischemic neurological deficit), and the problem having been recorded as ''new'' by the GP registrar.
Independent variables
Other variables related to the patient, registrar, practice, and consultation.
Patient factors were age and gender. Registrar factors were gender, training term, and place of medical qualification (Australia or international).
Practice factors included practice size (full-time equivalent number of GPs), routinely bulk bills (i.e., there is no financial cost to the patient for the consultation), rurality, and socioeconomic status of the practice location. Practice postcode was used to define the Australian Standard Geographical Classification-Remoteness Area (ASGC-RA) classification 18 (the degree of rurality) and the Socioeconomic Index for Areas (SEIFA) Index of Disadvantage 19 of the practice location reported as a decile. The lower the SEIFA score, the more disadvantaged the area. Consultation factors were duration of consultation, whether the registrar sought clinical information or assistance during the consultation (from their GP supervisor, a specialist, other health professional, or from electronic or hard-copy resources), and whether they generated any ''learning goals'' (clinical questions to be pursued after the consultation had finished).
Medications prescribed were classified using the Anatomic Therapeutic Chemical (ATC) Classification codes: 20 antiplatelets (B01AC06, B02AC07, B01AC04, A01AD05, N02BA01), anticoagulants (B01AA03, B01AB, B01AE, B01AF), antihypertensives (C02, C03, C07, C08, C09), and statins (C10AA).
Data analysis
The proportion of all problems that were a ''new TIA'' was calculated with 95% confidence interval (95% CI).
Associations of a registrar seeing a ''new TIA''
Univariate and multivariable analyses were conducted with outcome factor ''new TIA'' (compared to all other problems).
Logistic regression was used within the generalized estimating equations (GEEs) framework to account for repeated measures within registrars. An exchangeable correlation structure was assumed.
Covariates with a p value < 0.20 and a relevant effect size in the univariate analysis were included in the multivariable regression model.
Covariates that had a small effect size and were no longer significant (at p < 0.05) in the multivariable model were removed from the final model as long as the covariate's removal did not substantively change the resulting model.
Management of TIA
The guidelines 8 recommend that a TIA be assessed with urgent imaging of the brain and the vessels supplying it, investigated with basic blood tests and an electrocardiogram, reviewed by a stroke specialist (within 24 h for high-risk TIA and seven days for low risk, as assessed by the ABCD2 score), and early initiation of secondary prevention consisting of antiplatelet therapy (or anticoagulant where required), initiation or intensification of antihypertensive therapy, and statin therapy. Lowrisk TIA should be managed in a specialist secondary care setting, but it is recognized that management may need to be in general practice if no specialist service is available. The guidelines specify that blood tests, brain and carotid imaging, and ECG should be initiated at the first point of health care contact, whether first seen in primary or secondary care. Thus, for presentations of ''new TIAs,'' we calculated (with 95% CIs) the proportion of presentations for which ''brain imaging'' (computed tomography or magnetic resonance imaging), ''arterial imaging'' (ultrasound, magnetic resonance angiogram, cerebral angiogram), and ''blood test'' (being any one of full blood count, electrolytes urea and creatinine, blood glucose, or fasting lipids being requested); the proportion of patients ''referred'' (to neurologist, general physician, emergency department, or hospital clinic); the proportion of patients for whom prescription was made for secondary prevention medications (being an antiplatelet or anticoagulant, antihypertensive, and statin); and, as a proxy for guideline compliance, the proportion of presentations for which there was ''action taken'' (the patient was either referred or all four of these actions occurred: brain imaging, arterial imaging, electrocardiogram, and any one of an antiplatelet, anticoagulant, antihypertensive, or statin prescribed). We adopted this approach because we do not have data for pre-existing medications. We expect that for the great majority of patients there will need to be at least one medication change made to comply with guideline recommendations for commencement or dose-intensification of secondary prevention medications. 5 We also assumed that referral was urgent and, though not entirely consistent with guidelines, would result in expedited investigation in secondary care.
Analyses were programmed using Stata 13.1 (Statacorp, College Station, TX, USA) and SAS V9.4 (SAS Institute Inc., Cary, NC, USA).
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Results
A total of 1331 registrars contributed 3259 rounds of data (response rate 95.8%). The characteristics of registrars and their practices are presented in Table 1 : 65.5% of registrars were female, 80.6% were initially qualified in Australia, 83.8% worked in major cities or inner regional areas, and 65.9% worked in practices with five or more GPs.
There were 250,625 problems (from 154,090 consultations) for patients aged 18 years or over, in the 14 rounds of data collection. Of these, 65 problems Characteristics of new TIA problems are summarized in Table 2 . Results for the multivariable model are presented in Table 3 . It shows GP registrars were significantly more likely to seek in-consultation help or advice for a new TIA problem, generate learning goals, and spend more time compared to other problems. GP registrars working in an inner regional location were significantly more likely to see a new TIA than their colleagues working in major cities. Older patient age was also significantly associated with a new TIA problem.
Management aspects of new TIA problems are presented in Table 4 : brain and arterial imaging was ordered in 15.4%, 38.5% were referred for specialized care, 36.9% had an antiplatelet prescribed but only 40.0% satisfied our ''action taken'' variable.
Discussion
The proportion of consultations entailing a new presentation of TIA to GP registrars in our study is very low (0.04%), as is that for TIA new or old (0.07%). This compares to 0.2% for management of TIA by established GPs in an earlier Australian study, 21 which reported all consultations for TIA and did not report specifically on new presentations. In comparison, a UK neurology trainee recorded all diagnoses (5246) encountered during training-of these 2.1% were TIA and 1.1% were new TIAs. 22 Whilst this is only a single trainee it highlights the gulf of experience between the GP and the expert. Our findings indicate that GP registrars have little exposure to TIA diagnosis and management. This low exposure may therefore limit opportunity to learn and embed best-practice management to reduce the risk of recurrent stroke. 5 Our data demonstrate an association between a new presentation of TIA and increasing age that is consistent with the epidemiology of TIA. 7 That GP registrars International Journal of Stroke, 13 (3) working at inner regional practices are more likely to see a new TIA than their major city counterparts is a finding with implications for health services delivery. The multivariable analysis indicates that managing a new TIA is not straightforward for GP registrars. The significant associations of a new TIA with longer consultations, increased likelihood of seeking help, and of generating learning goals strongly suggest that GP registrars find TIA a particularly challenging presentation, consistent with recent qualitative findings.
11 GP registrars are not alone in finding TIA challenging, as there is evidence that established GPs and emergency department physicians find diagnosis difficult. 11, 23 Even agreement between stroke-trained neurologists can be poor for TIA diagnosis. 24 However, having reached a diagnosis of TIA, it is reasonable to expect adherence to management guidelines.
There was limited adherence with guideline recommendations for all elements of TIA management with 15.4% ordering brain and arterial imaging, 36.9% prescribing protective antiplatelet medication, 3.1% prescribing antihypertensive medication, and 38.5% being referred. Only 40.0% of new TIA problems met our proxy measure for adequate guideline compliance. This suggests management of new TIA problems is far from ideal (even when assuming optimal rapid assessment and management of patients who were referred). There were low proportions of relevant imaging, investigations, and secondary prevention. Our findings are concerning because rapid early management of suspected TIA at first medical contact is an opportunity for effective prevention of recurrent stroke. 5 
Limitations and strengths
Our study's high response rate, unusual for studies in general practice, 25 is a strength. The proxy marker for guideline compliance, ''action taken,'' is an imprecise marker for appropriate management of TIA, as we cannot determine the urgency of referrals, whether patients attended appointments or complied with treatments and investigations. Also, our ascertainment of prescribed pharmacotherapy is limited by our lack of information relating to the patient's preexisting medications. The EXPRESS study 5 of a TIA clinic in Oxford, UK, demonstrated that after a TIA, antiplatelet therapy was initiated in over 57% of patients, clopidogrel (usually in addition to aspirin) in over 50%, a statin in over 70%, a first antihypertensive medication in over 60% and almost 40% had a second antihypertensive commenced. Consequently, initiation of new medicines or intensification of existing medications would be expected actions in the great majority of new TIAs and our methodology would capture this. In defining ''action taken,'' we required only one of the secondary prevention medications to be initiated or intensified during the consultation. Guidelines require three classes of medication to be addressed (antiplatelet or anticoagulant, antihypertensive, and statin). We also assumed referral to be urgent and to result in expedited investigation. Consequently, our measure would tend to overestimate the compliance with guidelines, which makes our finding of less than ideal compliance robust. The study relies upon the GP registrar identifying the problem as a TIA, and so our estimate of prevalence of new TIA presentations is subject to a risk of both underreporting and overreporting. But our findings of registrars' compliance with recommended investigation, management, and referral are robust, given that these are contingent upon the registrar's diagnosis at the time of the consultation and that we have consultation-level documentation of the actual clinical behavior and management choices of the GP registrars.
Implications for practice and further research
The challenging nature of TIAs for GPs and GP registrars is not likely to be just because of the inherent complexity of the problem but also because it is a relatively rare general practice presentation (meaning there is little opportunity to reinforce guideline management processes). However, the majority of TIAs do present in general practice 9 and therefore designing a model of care for TIA that enhances the ability of GPs to comply with the guidelines would have the greatest impact upon achieving best practice management of TIA. Increased access to acute TIA clinics would meet this challenge, 26 but would be very resource-intensive and logistically problematic in many areas, especially in areas outside major cities (including inner regional areas where our data suggest GPs are more likely to be consulted for TIAs). In the absence of urgent access to face-to-face specialist care for many GPs and their patients with TIA, access to real-time specialist advice may be an alternative. A rapid access TIA telemedicine clinic could meet this need and be a major part in transforming care for TIA, as has been achieved with acute stroke care. 27 Rather than suffer diagnostic uncertainty and the risk, it represents to compliance with secondary prevention while waiting for specialist review, a telemedicine clinic could offer early confirmation of diagnosis, regardless of geographic location of the patient, plus appropriate and timely follow-up to ensure secondary prevention is firmly established when needed. 11 Future research could assess the utility of a telemedicine TIA service. For GP registrars, our findings also suggest that education regarding early management of TIA is important.
Conclusion
TIA is a challenging problem for both early career GPs and established GPs. However, most patients with a TIA first present to general practice and therefore it is vital that appropriate management is commenced as early as possible in this setting. Given the relatively rare frequency of TIA presentations to an individual GP, an enhanced model of care that provides rapid access to expert TIA support and follow-up in general practice could help achieve best practice management.
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